Purchase Order SPE2DP17P0224
Award Date
1/9/17
Potential Completion Date
2/8/17
Potential Value
$1.1M
Federal Agency
Medical Supply Chain
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services to Glaxosmithkline, LLC to provide influenza and hepatitis vaccines for government stockpiling efforts. The $107,362.72 contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). There was no set-aside designation for this order. Glaxosmithkline, a major pharmaceutical company, has been awarded multiple federal contracts and indefinite delivery vehicles to supply...
This federal contract award, valued at $1,853,610.00, was granted to GlaxoSmithKline, LLC for the delivery of inactivated hepatitis A vaccines. The contract was awarded by the Defense agency Medical Supply Chain. It is a firm fixed price purchase order with no set-aside designation. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other medical products to various U.S. government agencies, has delivered these hepatitis A vaccines as part of their role as a prime contractor on...
This federal contract award to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company, is for the supply of GSK Travel Vaccines. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price (FFP) pricing type, valued at $117,000.00, and has an ultimate completion date of December 31, 2025. The award was made on February 27, 2025 by the Department of Justice, Headquarters Division, a civilian federal agency. Glaxosmithkline, LLC has been awarded multiple...
This is a $282,489.95 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company. The contract is for the provision of pharmaceutical products, including influenza virus and hepatitis vaccines, COVID-19 treatments, vaccine adjuvants, and antiviral medications, to support disease prevention efforts, immunization programs, drug stockpiling initiatives,...
This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to the prime contractor Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines for the government's stock. The $172,923.02 firm fixed price delivery order was issued under Glaxosmithkline's Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs. The award does not have a set-aside designation. Glaxosmithkline is a...
This is a $144,059.82 firm fixed price delivery order awarded by the Department of Health and Human Services to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines and other pharmaceutical products. The contract is issued under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The delivery order supports disease prevention efforts, immunization programs, and healthcare services, with performance in...
This is a $105,351.10 delivery order contract awarded by the Department of Health and Human Services (HHS) to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, for the supply of vaccines. The contract is not set-aside and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The vaccines will be delivered from Glaxosmithkline's facilities in Research Triangle Park, North Carolina. Glaxosmithkline has a range of federal...
This is a firm fixed price delivery order award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, by the U.S. Department of Health and Human Services Office of the Assistant Secretary for Administration. The $157,037.17 award is for the provision of vaccines to support federal immunization programs. The contract was issued under Glaxosmithkline's existing General Services Administration Federal Supply Schedule contract for pharmaceuticals and drugs, with no set-aside designation....
This is a firm fixed price delivery order awarded by the Tennessee National Guard, a defense agency, to Glaxosmithkline, LLC for the provision of hepatitis A and B vaccines. The contract has a ceiling value of $32,345.80 and a performance period ending on September 13, 2022. The contract was awarded on a non-set-aside basis. Glaxosmithkline is a pharmaceutical company that regularly provides vaccines, antivirals, and other medical products to various U.S. government agencies, including the...
The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...